Precision Diagnostics & Medicine Market worth $246.66 billion by 2029

Browse 416 market data Tables and 92 Figures spread through 445 Pages and in-depth TOC on "Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029
The report "Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029", is expected to reach USD 246.66 billion by 2029 from USD 145.53 billion in 2024, growing at a CAGR of 11.1% Factors such as the increasing integration of AI and ML for the development of advanced precision diagnostics and therapeutic solutions supported by the rising collaboration and investment by major pharmaceutical companies for the development of precision medicine and biomarker discovery drive the growth of the market. Moreover, the increasing demand for direct-to-consumer testing owing to the growing awareness of patients towards their health and the convenience offered by these tests supports the adoption of precision diagnostics. Additionally, the expanding focus of pharmaceutical companies on the development of precision solutions for other diseases such as neurodegenerative disorders and autoimmune diseases and the integration of wearable technology to enhance healthcare offers growth opportunities for players operating in the precision medicine market. However, factors such as the high cost of precision healthcare and the challenges related to the integration and management of big data in precision solution development restrain the growth of the market.

Browse 416 market data Tables and 92 Figures spread through 445 Pages and in-depth TOC on "Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029"View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/precision-medicine-market-215185595.html

The monoclonal antibodies segment accounted for the largest share of the Precision Medicine Market, by product, during the forecast period.

Based on products, the precision medicine market is divided into inhibitor drugs, monoclonal antibodies, cell and gene therapy, antiviral and anti-retroviral drugs, and other therapeutic products. The large share of the monoclonal antibodies products segment can be attributed to the fact that a large number of the approved precision therapies are monoclonal antibodies. This large share of this segment is also supported by the ongoing approvals for monoclonal antibody drugs for various cancers and other diseases highlighting a focus of pharmaceutical companies on the development of monoclonal antibodies as precision medicines.

The oncology subsegment accounted for the largest share of the precision diagnostics market's indication segment in 2023

Based on indication, the precision diagnostics market is segmented into oncology, neurology, immunology, and other indications. The oncology segment accounted for the largest share of the precision diagnostics market by indication in 2023. The large share of this segment is attributed to the increase in cancer cases globally, supported by rising demand for diagnostic tests offering early and accurate cancer diagnosis. For this reason, life science companies are increasingly investing and collaborating to develop advanced oncology diagnostic tests. This dominance is expected to continue throughout the forecast period as major players are developing new technologies for better oncology diagnosis.

Asia Pacific is registered as the fastest-growing region of the Precision diagnostics market in 2023.

The Precision medicine market is divided into five regions, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2023, North America held the largest share of the precision diagnostics market, followed by Europe. Aisa Pacific registered the highest CAGR growth within the precision diagnostics market during the forecast period. The expansion of key diagnostic players in the region followed by favorable policies supporting the larger adoption of precision medicine is a supporting factor. Additionally, there is a greater awareness about personalized approach to treatments in these developed regions compared to the developing/ emerging economies.

Key players in the Precision diagnostic market include F. Hoffman La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), and Guardant Health (US) among others and key players in precision medicine market include Merck Co, Inc. (US), Gilead Sciences (US), AstraZeneca (UK), Novartis AG (Switzerland), among others.

Don't miss out on business opportunities in Precision Diagnostics & Medicine Market. Speak to our analyst and gain crucial industry insights that will help your business grow. [https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=215185595&utm_source=abnewswire.com]

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=precision-diagnostics-medicine-market-worth-24666-billion-by-2029]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/precision-medicine-market-215185595.html

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.